GB2178314B - Vasodilating and antianoxic compositions containing ubiquinone coenzymes. - Google Patents

Vasodilating and antianoxic compositions containing ubiquinone coenzymes.

Info

Publication number
GB2178314B
GB2178314B GB8618249A GB8618249A GB2178314B GB 2178314 B GB2178314 B GB 2178314B GB 8618249 A GB8618249 A GB 8618249A GB 8618249 A GB8618249 A GB 8618249A GB 2178314 B GB2178314 B GB 2178314B
Authority
GB
United Kingdom
Prior art keywords
antianoxic
vasodilating
coenzymes
compositions containing
containing ubiquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB8618249A
Other languages
English (en)
Other versions
GB2178314A (en
GB8618249D0 (en
Inventor
Pierre-Noel Brasey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seuref AG
Original Assignee
Seuref AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref AG filed Critical Seuref AG
Publication of GB8618249D0 publication Critical patent/GB8618249D0/en
Publication of GB2178314A publication Critical patent/GB2178314A/en
Application granted granted Critical
Publication of GB2178314B publication Critical patent/GB2178314B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8618249A 1985-08-02 1986-07-25 Vasodilating and antianoxic compositions containing ubiquinone coenzymes. Expired - Fee Related GB2178314B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3344/85A CH670763A5 (enExample) 1985-08-02 1985-08-02

Publications (3)

Publication Number Publication Date
GB8618249D0 GB8618249D0 (en) 1986-09-03
GB2178314A GB2178314A (en) 1987-02-11
GB2178314B true GB2178314B (en) 1990-02-21

Family

ID=4253937

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8618249A Expired - Fee Related GB2178314B (en) 1985-08-02 1986-07-25 Vasodilating and antianoxic compositions containing ubiquinone coenzymes.

Country Status (9)

Country Link
US (1) US4778798A (enExample)
JP (1) JPS6253932A (enExample)
BE (2) BE905198A (enExample)
CH (1) CH670763A5 (enExample)
DE (1) DE3625877A1 (enExample)
FR (1) FR2591481B1 (enExample)
GB (1) GB2178314B (enExample)
IT (1) IT1197061B (enExample)
NL (1) NL8601977A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
FR2655854A1 (fr) * 1989-12-19 1991-06-21 Poissonnet Claude Medication nouvelle pour le traitement de surcharges lipidiques.
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
CA2272971C (en) * 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
DE19928528C2 (de) * 1999-06-22 2002-10-17 Heinz Kiefer Arzneimittel (Antiarteriosklerotikum) zur Vorbeugung und Linderung von Beschwerden bei arteriellen Durchblutungsstörungen auf der Grundlage von Ginkgobiloba
GB2368012A (en) * 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
GB0209254D0 (en) * 2002-04-23 2002-06-05 Larkins Nicholas J Preparation for the relief of disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100915A2 (en) * 1982-07-15 1984-02-22 Eisai Co., Ltd. Hair grower composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5938203B2 (ja) * 1976-04-26 1984-09-14 エーザイ株式会社 補酵素ｑを主成分とする脳循環障害治療剤
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100915A2 (en) * 1982-07-15 1984-02-22 Eisai Co., Ltd. Hair grower composition

Also Published As

Publication number Publication date
BE905211A (nl) 1987-02-04
IT1197061B (it) 1988-11-25
DE3625877A1 (de) 1987-02-05
CH670763A5 (enExample) 1989-07-14
BE905198A (nl) 1986-11-17
JPS6253932A (ja) 1987-03-09
NL8601977A (nl) 1987-03-02
GB2178314A (en) 1987-02-11
IT8621393A1 (it) 1988-02-01
GB8618249D0 (en) 1986-09-03
IT8621393A0 (it) 1986-08-01
FR2591481A1 (fr) 1987-06-19
FR2591481B1 (fr) 1992-05-29
US4778798A (en) 1988-10-18
DE3625877C2 (enExample) 1992-04-02

Similar Documents

Publication Publication Date Title
GB8702216D0 (en) Protective envelope
GB8621580D0 (en) Composition
GB8531635D0 (en) Composition
GB2179338B (en) Composition
GB8514052D0 (en) Compositions
OA08347A (en) Gazoline composition.
GB8600767D0 (en) Composition
GB8509409D0 (en) Compositions
GB8622856D0 (en) Composition
GB8604135D0 (en) Composition
GB8609294D0 (en) 1-hydroxy-8-acyloxy-10-acyl anthrones
GB8504489D0 (en) Aminomethylenephosphonate compositions
IL78585A0 (en) Organopolysiloxane composition
GB8513550D0 (en) Compositions
GB8514418D0 (en) Aminobenzylamine composition
EP0225309A3 (en) Aminomethylenephosphonate compositions
GB8606846D0 (en) Composition
GB8501400D0 (en) Compositions
GB8503041D0 (en) Reamers
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
CA54698S (en) Fuseholder
EG17458A (en) Fungicial compositions
IE851607L (en) Organopolysiloxane composition
CS684185A1 (en) Sposob merania dlzky koncovych mierokna dvoch vzajomne spojenych dvojlucovych interferometroch pomocou vlnovej dlzky (he ne) lasera
ZA861586B (en) Letter/envelope combination

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930725